CANAQUEST MEDICAL CORP announces filing of CANNABIS/BOTANICAL PROVISIONAL PATENTS
05. Februar 2019 09:30 ET
|
CanaQuest Medical Corp
UNIQUE BOTANICAL AND TETRAHYDROCANNABINOL (“THC’) FORMULATION TREATING PSYCHIATRIC DISORDERS WITHOUT THE NEGATIVE PSYCHIATRIC SIDE-EFFECTS OF THC TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- ...